Raylytic GmbH
8
3
4
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
25.0%
2 terminated/withdrawn out of 8 trials
0.0%
-86.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant
Role: collaborator
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex
Role: collaborator
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Role: collaborator
Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
Role: collaborator
Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy 3
Role: collaborator
Study to Evaluate the Performance of Navigated TKA With OrthoPilot® pheno4u TKA Level 1
Role: collaborator
In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
Role: collaborator
Prospective Study on Ennovate® Pedicle Screw Fixation in Isthmic Spondylolisthesis Patients
Role: collaborator
All 8 trials loaded